AFFLUENT MEDICAL hosted a Key Opinion Leader event Wednesday, May 23, 2018 on New Generation Technologies for Minimally Invasive Surgery of the Mitral Valve and Abdominal Aorta.
Key opinion leaders (KOLs) present were Professor Christian Latrémouille (Georges Pompidou European Hospital) and Professor Stéphan Haulon (Université Paris Sud) who discussed novel surgical technologies for the treatment of mitral valve regurgitation and abdominal aortic aneurysm.
AFFLUENT MEDICAL’s CEO Daniele Zanotti and Chief Medical Officer Dr. Marcio Scorsin also provided an overview of the Company’s cardiovascular franchise, including the Epygon transcatheter mitral valve implant (TMVI); the Kalios adjustable mitral valve repair device; and Kardiozis endo-prosthesis for treating the abdominal aortic aneurysm aimed at the prevention of endoleaks.